Navigating ALK-positive Clinical Trials: Facts Timelines, and Real Expectations On Sunday, March 29 at 7:00pm ET, Dr. Riess and Johanna Han joined ALKtALK for an educational conversation focused on ALK+ cancer clinical trials, including single-patient INDs (Investigational New Drugs)—what they are, what they are not, and what patients and care partners should realistically expect when […]

